	Lung Cancer Diagnosis and Prognostic Monitoring Through Cell-Free RNA via Liquid Biopsy. Ther Clin Risk Manag Pan Y, Jiang C, Ye M, Li D, Wang J. PMID: 41367889 [PubMed]
	CD44 targeted functionalized nanocarriers for non-small cell lung cancer. Front Oncol Zhu N, Guo R, Jiang Y, Xu M. PMID: 41367861 [PubMed]
	An interpretable machine learning model for predicting visceral pleural invasion in cT1 lung adenocarcinoma based on habitat analysis. Quant Imaging Med Surg Gan X, Zhang W, Shen Z, Chen W, Duan X, Dai H, Chen J, Chen B. PMID: 41367764 [PubMed]
	Abbreviated dynamic total-body [(18)F]FDG PET/CT protocols for predicting response in locally advanced non-small cell lung cancer via Patlak-Ki analysis. Quant Imaging Med Surg Zheng S, Zhou R, Mo Y, Liu H, Liu F, Qiu B, Zhang W, Fan W, Lin Y, Wang D, Liu H. PMID: 41367744 [PubMed]
	Pulmonary cryptococcosis coexisting with lung cancer: a Chinese multicenter retrospective study. Quant Imaging Med Surg Deng H, Xie M, Zhang C, Shi Y, Pan L, Han W, Zhou Y, Zhao E, Hu Q, Yi L, Liang Y, Feng J, Cao O, Wang K, Wu D, Xue X. PMID: 41367724 [PubMed]
	Carrageenan grafted with acrylic acid and sulfonamide induces apoptosis and suppresses proliferation in A549 lung cancer cells: synthesis, cytotoxicity, gene expression, and in silico studies. RSC Adv Hashem MS, Fahim AM, Elsayed GH. PMID: 41367704 [PubMed]
	The pathogenesis and therapeutic management of rare pulmonary sarcomatoid carcinoma: a narrative review. Transl Lung Cancer Res Wang Q, Guo H, Wang Y, He T, Diao M, Wu Y, Xiong A, Zhou F, Li W, Cheng L, Zhao C, Li X, Zhou C. PMID: 41367587 [PubMed]
	A public data-based molecular classification of small cell lung cancer by neuroactive signaling networks unveils distinct microenvironment landscapes and immunotherapy-related prognostic biomarkers. Transl Lung Cancer Res Zhou W, Tang Y, Zeng J, Zhang X, Meng H, Guan W, Zhu Y, Jiang H, Wang Y, Xie X, Zhou C, Liu M. PMID: 41367585 [PubMed]
	Treatment interruption during neoadjuvant immuno-chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of randomized controlled trials. Transl Lung Cancer Res Liu Y, Wang Z, Ma S, Yang Z, Li Y, Yasheng A, Deng Z, Liu Z, Li C, Xia L, Zhou L, Liu C. PMID: 41367584 [PubMed]
	A narrative review of pathologic response in non-small cell lung cancer: challenges, implications, and future directions. Transl Lung Cancer Res Li Y, Liang F, Xiao S, Yuan C, Chen H. PMID: 41367582 [PubMed]
	Exosomal biomarkers and therapeutics in lung cancer: a narrative review on their role in early detection and targeted treatment. Transl Lung Cancer Res Rodríguez-Sanz J, Mincholé Lapuente E, Polanco Alonso D, Viñuales Aranda MD, Marín-Oto M, Domingo Morera JA, Marín Trigo JM, Sanz-Rubio D. PMID: 41367581 [PubMed]
	Redefining treatment interval in lung cancer surgery in the era of prehabilitation: a systematic review. Transl Lung Cancer Res Geomini LD, van Steenwijk QCA, Janki S, Hoogendoorn I, Slooter GD, van den Broek FJC, Marres GMH. PMID: 41367578 [PubMed]
	Real-world first-line outcomes of alectinib and brigatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: a nationwide South Korean cohort study using the health insurance review and assessment data. Transl Lung Cancer Res Kim HJ, Lee EA, Park JH, Lee HW. PMID: 41367570 [PubMed]
	Alectinib versus crizotinib as the first-line treatment in patients with advanced ALK-positive non-small cell lung cancer: a Chinese real-world cohort study. Transl Lung Cancer Res Zhang H, Wu Z, Lu T, Zhang H, Li J, Zhang D, Yu S, Guo X, Feng X, Liu J, Shi Y, Gao X, Liu X, Chen M, Zhao J, Zhong W, Hu Y, Xu Y, Wang M. PMID: 41367568 [PubMed]
	Prognostic impact of ALK rearrangement in surgically treated stage I lung adenocarcinoma: a retrospective cohort study. Transl Lung Cancer Res Huang Y, Zhou J, Shen C, Yang R, Zheng Q, Qiu Y, Mei X, Wu K, Wu D, Wang J, Jiang W, Liao H. PMID: 41367560 [PubMed]
	Comparison of efficacy and surgery-related safety of perioperative tislelizumab and pembrolizumab with neoadjuvant chemotherapy for resectable non-small cell lung cancer: a retrospective cohort study. Transl Lung Cancer Res Li Y, Jiang J, Yao X, Wang Z, Shao C, Wang J, Lei J, Zhao J, Aoki M, Adachi H, Ni Y, Liu Y, Duan H, Yan X. PMID: 41367559 [PubMed]
	PD-L1 expression in primary lung tumor as a superior predictive biomarker to metastatic lymph nodes for first-line immunochemotherapy in advanced KRAS-mutant non-small cell lung cancer. Transl Lung Cancer Res Jin H, Zhang Y, Huang H, Xu J, Xu Y, Wu Y, Liu T, Zhong H, Chen J, Miao Q, Zhong R. PMID: 41367552 [PubMed]
	The mortality and trends of lung cancer among females in urban and rural China, 2004 to 2018: A cohort study. Medicine (Baltimore) Liu H, Shi Y, Zhao L, Cui G, Wang D, Li X, Chen Y. PMID: 41367027 [PubMed - indexed for MEDLINE]
	The impact of VATS anatomic segmentectomy on postoperative stress response and respiratory function in early-stage NSCLC patients. Medicine (Baltimore) Sun J, Sheng Y, Yang T. PMID: 41366977 [PubMed - indexed for MEDLINE]
	18F-FDG PET/CT radiomics for distinguishing LUAD from LUSC in non-small cell lung cancer. Medicine (Baltimore) Qin J, Ge Z, Zeng YL, Li JZ, Mu XY, Zhu XY, Li ZG, Chong WX, Zhang L, Mo BY, Fu W. PMID: 41366896 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 155599

Page 1 of 7780



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy